Treatment of Cushing’s Disease with Pituitary-Targeting Seliciclib

By sjmartinez • October 11, 2022

Liu NA, Ben-Shlomo A, Carmichael JD, Wang C, Swerdloff RS, Heaney AP, Barkhoudarian G, Kelly D, Noureddin M, Lu L, Desai M, Stolyarov Y, Yuen K, Mamelak AN, Mirocha J, Tighiouart M, Melmed S. Treatment of Cushing's Disease with Pituitary-Targeting Seliciclib. J Clin Endocrinol Metab. 2022 Oct 10:dgac588. doi: 10.1210/clinem/dgac588. Epub ahead of print. PMID: 36214832.

Tags: adrenocorticotrophic hormone, cortisol, Cushing’s disease, Endocrinology, pituitary adenoma, Publications

Metabolic atlas of early human cortex reveals glycolytic remodeling and pentose phosphate pathway control of cell fate transitions

Mil J, Soto JA, Krall AS, Peloggia J, Frigui S, Fong OS, Sathe L, Matulionis N, Day F, Stiles L, Montales KP, Azizad DJ, Gonzalez[...]

Primary Hyperparathyroidism-Downstream Consequences of Untreated Disease

Yeh MW. Primary Hyperparathyroidism-Downstream Consequences of Untreated Disease. JAMA Surg. 2026 Jul 29. doi: 10.1001/jamasurg.2026.3047. Epub ahead of print. PMID: 42525393.

DGAT1-associated lipid-retinoid dysregulation correlates with metabolic impairment in the RPE of Stargardt disease

Dave A, Ng ESY, Jiang Z, Hu J, Tatang J, Paniagua A, Doeve J, Parikh S, Williams KJ, Stiles L, Radu RA. DGAT1-associated lipid-retinoid dysregulation[...]